Works matching IS 10538569 AND DT 2006 AND VI 15 AND IP 12
Results: 8
The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 12, p. 852, doi. 10.1002/pds.1327
- By:
- Publication type:
- Article
Development of active safety surveillance system for traditional Chinese medicine: an empirical study in treating climacteric women.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 12, p. 889, doi. 10.1002/pds.1340
- By:
- Publication type:
- Article
Risk management planning: time to deliver.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 12, p. 850, doi. 10.1002/pds.1326
- By:
- Publication type:
- Article
A call for international harmonization in therapeutic risk management.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 12, p. 839, doi. 10.1002/pds.1319
- By:
- Publication type:
- Article
Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 12, p. 861, doi. 10.1002/pds.1343
- By:
- Publication type:
- Article
Mortality in schizophrenia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 12, p. 873, doi. 10.1002/pds.1325
- By:
- Publication type:
- Article
Current awareness: Pharmacoepidemiology and drug safety.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 12, p. i, doi. 10.1002/pds.1185
- Publication type:
- Article
Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 12, p. 880, doi. 10.1002/pds.1302
- By:
- Publication type:
- Article